Since January 22nd, 2026, Accellix is part of bioMérieux, a world leader in the field of in vitro diagnostics.

Learn more about this strategic acquisition.

WATCH PRESENTATION

Leukopak to Cell Therapy (By the Leukopak Lady)

To Access Video, Please Complete this Form:

    Interest*